<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07640187920406</udiDi>
    <basicUdiDi>B-07640187920406</basicUdiDi>
    <tradeName>Aliaxin EV - Essential Volume (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin EV - Essential Volume (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:13.400Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920383</udiDi>
    <basicUdiDi>B-07640187920383</basicUdiDi>
    <tradeName>Aliaxin FL - Lips (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin FL - Lips (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:55.714Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920376</udiDi>
    <basicUdiDi>B-07640187920376</basicUdiDi>
    <tradeName>Aliaxin GP - Global Performance (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin GP - Global Performance (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:54.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920369</udiDi>
    <basicUdiDi>B-07640187920369</basicUdiDi>
    <tradeName>HA Dermal Filler 2.0 - F4</tradeName>
    <deviceName>HA DERMAL FILLER 2.0</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HA Dermal Filler 2.0 - F4</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:54.115Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920352</udiDi>
    <basicUdiDi>B-07640187920352</basicUdiDi>
    <tradeName>HA Dermal Filler 2.0 - F3</tradeName>
    <deviceName>HA DERMAL FILLER 2.0</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HA Dermal Filler 2.0 - F3</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:53.312Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920345</udiDi>
    <basicUdiDi>B-07640187920345</basicUdiDi>
    <tradeName>ZHOABEX PHORMA</tradeName>
    <deviceName>ALIAXIN/NUAVIS</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX PHORMA</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:49.312Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920338</udiDi>
    <basicUdiDi>B-07640187920338</basicUdiDi>
    <tradeName>ZHOABEX SUPREME</tradeName>
    <deviceName>ALIAXIN/NUAVIS</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX SUPREME</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:47.713Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920321</udiDi>
    <basicUdiDi>B-07640187920321</basicUdiDi>
    <tradeName>ZHOABEX SUPER VOLUME</tradeName>
    <deviceName>LMW-CL-HA FACE/BODY</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>ZHOABEX SUPER VOLUME</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:46.916Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920314</udiDi>
    <basicUdiDi>B-07640187920314</basicUdiDi>
    <tradeName>ZHOABEX PERFORMANCE</tradeName>
    <deviceName>LMW-CL-HA ARTHRO</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>ZHOABEX PERFORMANCE</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:46.112Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920307</udiDi>
    <basicUdiDi>B-07640187920307</basicUdiDi>
    <tradeName>ZHOABEX ADVANCE</tradeName>
    <deviceName>HA DERMAL FILLER 2.0</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>ZHOABEX ADVANCE</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:42.116Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920291</udiDi>
    <basicUdiDi>B-07640187920291</basicUdiDi>
    <tradeName>ZHOABEX ENHANCE</tradeName>
    <deviceName>HA DERMAL FILLER 2.0</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>ZHOABEX ENHANCE</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:41.310Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920284</udiDi>
    <basicUdiDi>B-07640187920284</basicUdiDi>
    <tradeName>MINIFIL FACE/BODY</tradeName>
    <deviceName>LMW-CL-HA FACE/BODY</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MINIFIL FACE/BODY</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:39.705Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920277</udiDi>
    <basicUdiDi>B-07640187920277</basicUdiDi>
    <tradeName>MINIFIL ARTHRO</tradeName>
    <deviceName>LMW-CL-HA ARTHRO</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MINIFIL ARTHRO</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:38.954Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920239</udiDi>
    <basicUdiDi>B-07640187920239</basicUdiDi>
    <tradeName>ZHOABEX G</tradeName>
    <deviceName>VAGINAL FILLER</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX G</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:34.906Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920222</udiDi>
    <basicUdiDi>B-07640187920222</basicUdiDi>
    <tradeName>ZHOABEX ARTHRO 1,6%</tradeName>
    <deviceName>INTRA ARTICULAR HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX ARTHRO 1,6%</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:34.109Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920215</udiDi>
    <basicUdiDi>B-07640187920215</basicUdiDi>
    <tradeName>ZHOABEX ARTHRO 0,8%</tradeName>
    <deviceName>INTRA ARTICULAR HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX ARTHRO 0,8%</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:33.307Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920208</udiDi>
    <basicUdiDi>B-07640187920208</basicUdiDi>
    <tradeName>ZHOABEX LIPS</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX LIPS</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:31.710Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920192</udiDi>
    <basicUdiDi>B-07640187920192</basicUdiDi>
    <tradeName>ZHOABEX VOLUME</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX VOLUME</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:27.705Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920185</udiDi>
    <basicUdiDi>B-07640187920185</basicUdiDi>
    <tradeName>ZHOABEX SOFT TOUCH</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX SOFT TOUCH</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:27.103Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920178</udiDi>
    <basicUdiDi>B-07640187920178</basicUdiDi>
    <tradeName>ZHOABEX LIGHT LINES</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ZHOABEX LIGHT LINES</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:29:26.098Z</lastUpdated>
  </row>
</eudamedExport>